Company Overview of MedImmune Oncology Inc.
MedImmune Oncology Inc., a pharmaceutical company, engages in the development and commercialization of products for patients with cancer and acquired immune deficiency syndrome. MedImmune Oncology Inc. was formerly known as U.S. Bioscience, Inc. As a result of acquisition of U.S. Bioscience, Inc. by MedImmune, LLC, U.S. Bioscience, Inc. name was changed. The company was founded in 1987 and is based in West Conshohocken, Pennsylvania. As of November 23, 1999, MedImmune Oncology Inc. operates as a subsidiary of MedImmune, LLC.
100 Front Street
One Tower Bridge
West Conshohocken, PA 19428
Founded in 1987
Key Executives for MedImmune Oncology Inc.
Similar Private Companies By Industry
|NSA International, Inc.||United States|
|MediProPharma, Inc.||United States|
|Sharp Corporation||United States|
|Virgin Instruments Corp.||United States|
|Cureline Clinical Consulting Partners||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Saint Louis, MO | EnvisionPosted: Mar 13
- Delaware | DuPontPosted: Mar 09
- San Francisco, CA | Life TechnologiesPosted: Mar 13
- San Jose, CA | Sony Corporation of AmericaPosted: Mar 14
Sponsored Financial Commentaries
To contact MedImmune Oncology Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.